Variant report
Variant | rs12613903 |
---|---|
Chromosome Location | chr2:190352834-190352835 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr2:190351757-190352948 | T-47D | breast: | n/a | n/a |
2 | ESR1 | chr2:190351716-190352959 | T-47D | breast: | n/a | n/a |
3 | JUND | chr2:190351760-190353028 | T-47D | breast: | n/a | n/a |
4 | CTCF | chr2:190352781-190352844 | GM10266 | blood: | n/a | n/a |
5 | FOXA1 | chr2:190351834-190352990 | T-47D | breast: | n/a | n/a |
6 | GATA3 | chr2:190351736-190352937 | T-47D | breast: | n/a | n/a |
7 | GATA3 | chr2:190351876-190352848 | MCF-7 | breast: | n/a | n/a |
8 | FOXA1 | chr2:190351742-190352922 | T-47D | breast: | n/a | n/a |
9 | ESR1 | chr2:190351808-190352850 | T-47D | breast: | n/a | n/a |
10 | EP300 | chr2:190352025-190352837 | MCF-7 | breast: | n/a | n/a |
11 | FOXA2 | chr2:190352572-190352837 | HepG2 | liver: | n/a | n/a |
12 | ESR1 | chr2:190351718-190352914 | T-47D | breast: | n/a | n/a |
13 | ESR1 | chr2:190351787-190352957 | T-47D | breast: | n/a | n/a |
14 | GATA3 | chr2:190351704-190352926 | T-47D | breast: | n/a | n/a |
15 | GATA3 | chr2:190351794-190352840 | MCF-7 | breast: | n/a | n/a |
16 | EP300 | chr2:190351603-190352997 | T-47D | breast: | n/a | n/a |
17 | ESR1 | chr2:190351833-190352932 | T-47D | breast: | n/a | n/a |
18 | ESR1 | chr2:190351712-190352883 | T-47D | breast: | n/a | n/a |
19 | JUND | chr2:190351758-190352955 | T-47D | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233996 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10166420 | 0.81[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs10175108 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[YRI][hapmap];0.84[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10198663 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[YRI][hapmap];0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs10207812 | 1.00[CHB][hapmap];0.94[JPT][hapmap] |
rs10210634 | 0.82[ASN][1000 genomes] |
rs10931417 | 0.82[ASN][1000 genomes] |
rs11677167 | 0.82[ASN][1000 genomes] |
rs11678414 | 0.89[CHB][hapmap];0.95[JPT][hapmap];0.88[AMR][1000 genomes];0.93[ASN][1000 genomes] |
rs12622720 | 1.00[ASN][1000 genomes] |
rs12623394 | 0.93[ASN][1000 genomes] |
rs12693539 | 0.91[ASN][1000 genomes] |
rs12693540 | 0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13009912 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs13015207 | 0.91[ASN][1000 genomes] |
rs13018252 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.83[ASN][1000 genomes] |
rs13035381 | 0.82[ASN][1000 genomes] |
rs1356976 | 0.83[ASN][1000 genomes] |
rs1520854 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.91[ASN][1000 genomes] |
rs1520856 | 0.83[ASN][1000 genomes] |
rs1520858 | 1.00[CHB][hapmap];0.95[JPT][hapmap] |
rs1520866 | 0.94[ASN][1000 genomes] |
rs1595749 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs16831454 | 0.81[AMR][1000 genomes];0.94[ASN][1000 genomes] |
rs1851104 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.85[ASN][1000 genomes] |
rs1866605 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[YRI][hapmap];0.87[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs1866606 | 0.82[ASN][1000 genomes] |
rs1898971 | 0.84[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1992295 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.91[ASN][1000 genomes] |
rs2304702 | 0.81[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs2351934 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs2882805 | 0.83[ASN][1000 genomes] |
rs4309611 | 0.87[AMR][1000 genomes];0.95[ASN][1000 genomes] |
rs4666775 | 0.94[ASN][1000 genomes] |
rs4667280 | 0.80[ASN][1000 genomes] |
rs4667284 | 1.00[CEU][hapmap];0.94[CHB][hapmap];0.90[JPT][hapmap];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs6434342 | 0.87[ASN][1000 genomes] |
rs6434343 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.81[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs6738193 | 0.91[ASN][1000 genomes] |
rs6747222 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.83[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs6752545 | 0.82[ASN][1000 genomes] |
rs734859 | 0.85[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs744556 | 0.93[ASN][1000 genomes] |
rs745742 | 0.90[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7556928 | 0.82[ASN][1000 genomes] |
rs7566093 | 0.82[ASN][1000 genomes] |
rs7574403 | 0.91[ASN][1000 genomes] |
rs8179541 | 0.94[CHB][hapmap];0.94[JPT][hapmap];0.96[ASN][1000 genomes] |
rs8179732 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes] |
rs893407 | 0.90[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs893408 | 0.93[ASN][1000 genomes] |
rs9677436 | 0.82[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv533029 | chr2:189812229-190554339 | Active TSS Enhancers Weak transcription Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
2 | nsv875615 | chr2:190215527-190444392 | Enhancers Weak transcription ZNF genes & repeats Active TSS Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
3 | nsv584062 | chr2:190272195-190376493 | Enhancers Active TSS Weak transcription Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:190335000-190366200 | Weak transcription | Ovary | ovary |
2 | chr2:190342400-190357000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:190349200-190365000 | Weak transcription | Fetal Intestine Large | intestine |
4 | chr2:190350800-190353000 | Enhancers | Liver | Liver |
5 | chr2:190351600-190353000 | Enhancers | Placenta | Placenta |
6 | chr2:190352200-190353000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
7 | chr2:190352600-190353000 | Enhancers | Rectal Smooth Muscle | rectum |